Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 7Terminated 5Unknown 4Active not recruiting 4Recruiting 3

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Nasopharyngeal Carcinoma 20Prostatic Neoplasms 7Breast Neoplasms 7Head and Neck Neoplasms 6Esophageal Squamous Cell Carcinoma 6Esophageal Neoplasms 6Rectal Neoplasms 4Radiation Injuries 4Carcinoma, Squamous Cell 4Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 3Nasopharyngeal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Recurrence 2Lung Neoplasms 2Vulvar Neoplasms 1Thyroid Neoplasms 1Sinonasal undifferentiated carcinoma 1Radiation 1Pathologic Complete Response 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ototoxicity 1Obesity 1Neurotoxicity Syndromes 1Neoplasms 1

Interventions

Oxaliplatin 47Capecitabine 46Fluorouracil 40Leucovorin 30Radiotherapy 25Irinotecan 20Chemoradiotherapy 14Bevacizumab 14Cetuximab 12Neoadjuvant Therapy 11Folfox protocol 11Chemotherapy, Adjuvant 11Laparoscopy 10XELOX 9Drug Therapy 9Surgical Procedures, Operative 6Robotic Surgical Procedures 5Radiation 5Mastectomy, Segmental 5Surveys and Questionnaires 4Radiotherapy, Intensity-Modulated 4Panitumumab 4Gemcitabine 4durvalumab 3Simvastatin 3Magnetic Resonance Spectroscopy 3Indocyanine Green 3FOLFOXIRI protocol 3tislelizumab 2regorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Rectal Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT04405206 2020-10-14

BJCC-R01

Peking University Cancer Hospital & Institute

Unknown
54 enrolled
Gastrointestinal

Rectal Neoplasms

NCT04340401 2020-07-09

Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen

Peking University Cancer Hospital & Institute

Phase 2 Unknown
25 enrolled
Gastrointestinal

Rectal Neoplasms

NCT00392470 2011-05-25

Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
20 enrolled
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT01340508 2011-04-22

Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer

National University Hospital, Singapore

Phase 2 Unknown
63 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡